Opportunities and challenges of point of care testing paradigms in the post-COVID era
Author:
- 3 March 2024
- journal article
- editorial
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 24 (3) , 135-137
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and preventionExpert Review of Molecular Diagnostics, 2024
- Fast detection of bacterial gut pathogens on miniaturized devices: an overviewExpert Review of Molecular Diagnostics, 2024
- We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Expert Review of Molecular Diagnostics, 2024
- A fast-track to fungal diagnosis: the potential of molecular diagnostics for fungi at the point of careExpert Review of Molecular Diagnostics, 2023
- Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan AfricaExpert Review of Molecular Diagnostics, 2023
- Implementing Individualized quality control plans and managing risk at the point-of-care for molecular diagnosticsExpert Review of Molecular Diagnostics, 2023
- Maintaining point of care testing capacity and pandemic preparedness in the post-COVID-19 eraExpert Review of Molecular Diagnostics, 2023
- Point-of-care testing for viral-associated pulmonary aspergillosisExpert Review of Molecular Diagnostics, 2023
- The potential for rapid antigen testing for mucormycosis in the context of COVID-19Expert Review of Molecular Diagnostics, 2023
- Point-of-care tests: the key to reducing antibiotic prescribing for respiratory tract infections in primary care?Expert Review of Molecular Diagnostics, 2023